GridelliC., the Elderly Lung Cancer Vinorelbine Italian Study Group: Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst, 91: 66–72, 1999.
2.
VariolP., NguyenL., TranchandB., PuozzoC.: A simultaneous oral/i.v. population pharmacokinetic model’ for vinorelbine. Eur J Clin Pharmacol, submitted for publication, 2002.
3.
Van HeugenJ.C., De GraeveJ., ZorzaG., PuozzoC.: New sensitive liquid chromatography method coupled with tandem mass spectrometric detection for the clinical analysis of vinorelbine and its metabolites in blood, plasma, urine and faeces. J Chro-matog, 926: 11–20, 2001.
4.
BealS.L., SheinerL.B.: NONMEM users’ guide. Ed NONMEM Project Group, University of California, San Francisco, USA, 1998.
5.
MartyM., FumoleauP., AdenisA., RousseauY., MerroucheY., RobinetG., PuozzoC.: Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors. Ann Oncol, 12: 1643–1649, 2001.
6.
NguyenL., TranchantB., PuozzoC., VariolP.: Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials. Br J Clin Pharmacol, in press, 2002.
7.
SorioR., RobieuxI., GalligioniE., FreschiA., ColussiA.M., CrevellariD., SaracchiniS., MonfardiniS.: Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer. Eur J Cancer, 33:301: 303, 1997.
